References

  1. National Center for Health Statistics. Health, United States, 2012: With Special Feature on Emergency Care. Hyattsville, MD. 2013. Accessed June 20, 2017.
  2. Lipton JA, Ship JA, Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc. 1993 Oct;124(10):115-121.
  3. Anderson R, Thomas DW. 'Toothache stories': a qualitative investigation of why and how people seek emergency dental care. Community Dent Health. 2003 Jun;20(2):106-111.
  4. Locker D, Grushka M. Prevalence of oral and facial pain and discomfort: preliminary results of a mail survey. Community Dent Oral Epidemiol. 1987 Jun;15(3):169-172.
  5. Nalliah RP, Allareddy V, Elangovan S, et al. Hospital emergency department visits attributed to pulpal and periapical disease in the United States in 2006. J Endod. 2011 Jan;37(1):6-9. doi: 10.1016/j.joen.2010.09.006. Epub 2010 Nov 12.
  6. Sessle BJ. Recent developments in pain research: central mechanisms of orofacial pain and its control. J Endod. 1986 Oct;12(10):435-444. doi: 10.1016/S0099-2399(86)80196-0.
  7. Ellis A, Bennett DL. Neuroinflammation and the generation of neuropathic pain. Br J Anaesth. 2013 Jul;111(1):26-37. doi: 10.1093/bja/aet128.
  8. Mense S. Sensitization of group IV muscle receptors to bradykinin by 5-hydroxytryptamine and prostaglandin E2. Brain Res. 1981 Nov 23;225(1):95-105.
  9. Hall JM. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol Ther. 1992 Nov;56(2):131-90.
  10. Sundqvist G, Lerner UH. Bradykinin and thrombin synergistically potentiate interleukin 1 and tumour necrosis factor induced prostanoid biosynthesis in human dental pulp fibroblasts. Cytokine. 1996 Feb;8(2):168-77.
  11. Goodis HE, Bowles WR, Hargreaves KM. Prostaglandin E2 enhances bradykinin-evoked iCGRP release in bovine dental pulp. J Dent Res. 2000 Aug;79(8):1604-7. doi: 10.1177/00220345000790081301.
  12. Butterworth JF 4th, Strichartz GR. Molecular mechanisms of local anesthesia: a review. Anesthesiology. 1990 Apr;72(4):711-34.
  13. Ulbricht W. Sodium channel inactivation: molecular determinants and modulation. Physiol Rev. 2005 Oct;85(4):1271-301. doi: 10.1152/physrev.00024.2004
  14. McLure HA, Rubin AP. Review of local anaesthetic agents. Minerva Anestesiol. 2005 Mar;71(3):59-74.
  15. Woda A. Pain in the trigeminal system: from orofacial nociception to neural network modeling. J Dent Res. 2003 Oct;82(10):764-8. doi: 10.1177/154405910308201001.
  16. Sessle BJ. Recent insights into brainstem mechanisms underlying craniofacial pain. J Dent Educ. 2002 Jan;66(1):108-12.
  17. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med. 2001 Aug 2;345(5):351-8. doi: 10.1056/NEJM200108023450507.
  18. Smith C. Pharmacology of local anaesthetic agents. Br J Hosp Med. 1994 Nov 2-15;52(9):455-60.
  19. Moore PA, Hersh EV. Local anesthetics: pharmacology and toxicity. Dent Clin North Am. 2010 Oct;54(4):587-99. doi: 10.1016/j.cden.2010.06.015.
  20. Giovannitti JA Jr, Rosenberg MB, Phero JC. Pharmacology of local anesthetics used in oral surgery. Oral Maxillofac Surg Clin North Am. 2013 Aug;25(3):453-65, vi. doi: 10.1016/j.coms.2013.03.003. Epub 2013 May 7.
  21. Xylocaine (lidocaine hydrochloride) injection; Xylocaine with epinephrine (lidocaine hydrochloride and epinephrine bitartrate) injection [Dentsply Pharmaceutical Inc.]. Revised 9/2006. Accessed June 20, 2017.
  22. Carbocaine (mepivacaine hydrochloride) injection, solution; Carbocaine with neo-cobefrin (mepivacaine hydrochloride and levonordefrin) injection, solution [Carestream Health, Inc.]. Revised 5/2012. Accessed June 20, 2017.
  23. Citanest plain (prilocaine hydrochloride) injection, solution; Citanest Forte with epinephrine), injection (prilocaine hydrochloride with epinephrine) injection, solution [Dentsply Pharmaceutical Inc.]. Revised 3/2011. Accessed June 20, 2017.
  24. Septocaine and epinephrine (articaine and epinephrine bitartrate) injection, solution [Septodont Inc.]. Revised 2/2011. Accessed June 20, 2017.
  25. Marcaine (bupivacaine hydrochloride and epinephrine bitartrate) injection, solution [Carestream Heath Inc.]. Revised 6/2013. Accessed June 20, 2017.
  26. Brandt RG, Anderson PF, McDonald NJ, et al. The pulpal anesthetic efficacy of articaine versus lidocaine in dentistry: a meta-analysis. J Am Dent Assoc. 2011 May;142(5):493-504.
  27. Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: a multifactorial concept. Reg Anesth Pain Med. 2004 Nov-Dec;29(6):564-75; discussion 524.
  28. Haas DA. An update on local anesthetics in dentistry. J Can Dent Assoc. 2002 Oct;68(9):546-51.
  29. Cummings DR, Yamashita DD, McAndrews JP. Complications of local anesthesia used in oral and maxillofacial surgery. Oral Maxillofac Surg Clin North Am. 2011 Aug;23(3):369-77. doi: 10.1016/j.coms.2011.04.009.
  30. Schwartz S. Local anesthesia in pediatric dentistry. dentalcare.com. Revised January 6, 2012.
  31. Moore PA. Preventing local anesthesia toxicity. J Am Dent Assoc. 1992 Sep;123(9):60-4.
  32. Hersh EV, Helpin ML, Evans OB. Local anesthetic mortality: report of case. ASDC J Dent Child. 1991 Nov-Dec;58(6):489-91.
  33. Chasteen JE, Hatch RA, Passon JC. Contamination of local anesthetic cartridges with acrylic monomer. J Am Dent Assoc. 1988 Mar;116(3):375-9.
  34. Meechan JG. Effective topical anesthetic agents and techniques. Dent Clin North Am. 2002 Oct;46(4):759-66.
  35. Yaacob HB, Noor GM, Malek SN. The pharmacological effect of xylocaine topical anaesthetic--a comparison with a placebo. Singapore Dent J. 1981 Nov;6(2):55-7.
  36. Holst A, Evers H. Experimental studies of new topical anaesthetics on the oral mucosa. Swed Dent J. 1985;9(5):185-91.
  37. Rosivack RG, Koenigsberg SR, Maxwell KC. An analysis of the effectiveness of two topical anesthetics. Anesth Prog. 1990 Nov-Dec;37(6):290-2.
  38. Primosch RE, Rolland-Asensi G. Comparison of topical EMLA 5% oral adhesive to benzocaine 20% on the pain experienced during palatal anesthetic infiltration in children. Pediatr Dent. 2001 Jan-Feb;23(1):11-4.
  39. Gill CJ, Orr DL 2nd. A double-blind crossover comparison of topical anesthetics. J Am Dent Assoc. 1979 Feb;98(2):213-4.
  40. Keller BJ. Comparison of the effectiveness of two topical anesthetics and a placebo in reducing injection pain. Hawaii Dent J. 1985 Dec;16(12):10-1.
  41. Martin MD, Ramsay DS, Whitney C, et al. Topical anesthesia: differentiating the pharmacological and psychological contributions to efficacy. Anesth Prog. 1994;41(2):40-7.
  42. Houpt MI, Heins P, Lamster I, et al. An evaluation of intraoral lidocaine patches in reducing needle-insertion pain. Compend Contin Educ Dent. 1997 Apr;18(4):309-1O, 312-4, 316; quiz 318.
  43. Hersh EV, Houpt MI, Cooper SA, et al. Analgesic efficacy and safety of an intraoral lidocaine patch. J Am Dent Assoc. 1996 Nov;127(11):1626-34; quiz 1665-6.
  44. DentiPatch® (lidocaine patch (Noven Pharmaceuticals, Inc.). Revised 7/2006. Accessed June 20, 2017.
  45. OraVerse (phentolamine mesylate) injection, solution for submucosal use (Novalar Pharmaceuticals). Revised 5/2008. Accessed June 20, 2017.
  46. Hersh EV, Moore PA, Papas AS, et al. Reversal of soft-tissue local anesthesia with phentolamine mesylate in adolescents and adults. J Am Dent Assoc. 2008 Aug;139(8):1080-93.
  47. Tavares M, Goodson JM, Studen-Pavlovich D, et al. Reversal of soft-tissue local anesthesia with phentolamine mesylate in pediatric patients. J Am Dent Assoc. 2008 Aug;139(8):1095-104.
  48. Daubländer M, Liebaug F, Niedeggen G, et al. Effectiveness and safety of phentolamine mesylate in routine dental care. J Am Dent Assoc. 2017 Mar;148(3):149-156. doi: 10.1016/j.adaj.2016.11.017. Epub 2017 Jan 23.
  49. Garisto GA, Gaffen AS, Lawrence HP, et al. Occurrence of paresthesia after dental local anesthetic administration in the United States. J Am Dent Assoc. 2010 Jul;141(7):836-44.
  50. Hillerup S, Jensen RH, Ersbøll BK. Trigeminal nerve injury associated with injection of local anesthetics: needle lesion or neurotoxicity? J Am Dent Assoc. 2011 May;142(5):531-9.
  51. Gaffen AS, Haas DA. Retrospective review of voluntary reports of nonsurgical paresthesia in dentistry. Accessed June 20, 2017.
  52. Falace DA, Hill JS. Allergy to lidocaine and mepivacaine: report of a case. Compend Contin Educ Dent. 1985 Apr;6(4):280, 282-4.
  53. Levy SM, Baker KA. Considerations in differential diagnosis of adverse reactions to local anesthetic: report of case. J Am Dent Assoc. 1986 Aug;113(2):271-3.
  54. MacColl S, Young ER. An allergic reaction following injection of local anesthetic: a case report. J Can Dent Assoc. 1989 Dec;55(12):981-4.
  55. Seng GF, Kraus K, Cartwright G, et al. Confirmed allergic reactions to amide local anesthetics. Gen Dent. 1996 Jan-Feb;44(1):52-4.
  56. Seng GF, Gay BJ. Dangers of sulfites in dental local anesthetic solutions: warning and recommendations. J Am Dent Assoc. 1986 Nov;113(5):769-70.
  57. Dooms-Goossens A, de Alam AG, Degreef H, et al. Local anesthetic intolerance due to metabisulfite. Contact Dermatitis. 1989 Feb;20(2):124-6.
  58. Townes PL, Geertsma MA, White MR. Benzocaine-induced methemoglobinemia. Am J Dis Child. 1977 Jun;131(6):697-8.
  59. Balicer RD, Kitai E. Methemoglobinemia caused by topical teething preparation: a case report. ScientificWorldJournal. 2004 Jul 15;4:517-20. doi: 10.1100/tsw.2004.109.
  60. Hegedus F, Herb K. Benzocaine-induced methemoglobinemia. Anesth Prog. 2005 Winter;52(4):136-9. doi: 10.2344/0003-3006(2005)52[136:BM]2.0.CO;2.
  61. LeClaire AC, Mullett TW, Jahania MS, et al. Methemoglobinemia secondary to topical benzocaine use in a lung transplant patient. Ann Pharmacother. 2005 Feb;39(2):373-6. Epub 2005 Jan 11. doi: 10.1345/aph.1E315.
  62. Gutta R, Louis PJ. Methemoglobinemia--an unusual cause of intraoperative hypoxia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Feb;103(2):197-202. Epub 2006 Sep 25. doi: 10.1016/j.tripleo.2006.05.006.
  63. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol. 2002 Feb 6;39(3):542-53.
  64. Niwa H, Satoh Y, Matsuura H. Cardiovascular responses to epinephrine-containing local anesthetics for dental use: a comparison of hemodynamic responses to infiltration anesthesia and ergometer-stress testing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Aug;90(2):171-81. doi: 10.1067/moe.2000.107534.
  65. FDA. Requirements on the content and format of labeling for human prescription drug and biological products. Code of Federal Regulations (CFR) Title 21, Part 201, Labeling (Revised on April 1, 2015). Accessed June 20, 2017.
  66. Eisenach JC, Grice SC, Dewan DM. Epinephrine enhances analgesia produced by epidural bupivacaine during labor. Anesth Analg. 1987 May;66(5):447-51.
  67. Laishley RS, Morgan BM. A single dose epidural technique for caesarean section. A comparison between 0.5% bupivacaine plain and 0.5% bupivacaine with adrenaline. Anaesthesia. 1988 Feb;43(2):100-3.
  68. Abboud TK, DerSarkissian L, Terrasi J, et al. Comparative maternal, fetal, and neonatal effects of chloroprocaine with and without epinephrine for epidural anesthesia in obstetrics. Anesth Analg. 1987 Jan;66(1):71-5.
  69. Abboud TK, David S, Nagappala S, et al. Maternal, fetal, and neonatal effects of lidocaine with and without epinephrine for epidural anesthesia in obstetrics. Anesth Analg. 1984 Nov;63(11):973-9.
  70. Abboud TK, Sheik-ol-Eslam A, Yanagi T, et al. Safety and efficacy of epinephrine added to bupivacaine for lumbar epidural analgesia in obstetrics. Anesth Analg. 1985 Jun;64(6):585-91.
  71. Skjöldebrand A, Eklund J, Lunell NO, et al. The effect on uteroplacental blood flow of epidural anaesthesia containing adrenaline for caesarean section. Acta Anaesthesiol Scand. 1990 Feb;34(2):85-9.
  72. Albright GA, Jouppila R, Hollmén AI, et al. Epinephrine does not alter human intervillous blood flow during epidural anesthesia. Anesthesiology. 1981 Feb;54(2):131-5.
  73. Jouppila R, Jouppila P, Kuikka J, et al. Placental blood flow during caesarean section under lumbar extradural analgesia. Br J Anaesth. 1978 Mar;50(3):275-9.
  74. Jouppila R, Jouppila P, Hollmén A, et al. Effect of segmental extradural analgesia on placental blood flow during normal labour. Br J Anaesth. 1978 Jun;50(6):563-7.
  75. Alahuhta S, Räsänen J, Jouppila R, et al. Effects of extradural bupivacaine with adrenaline for caesarean section on uteroplacental and fetal circulation. Br J Anaesth. 1991 Dec;67(6):678-82.
  76. Alahuhta S, Räsänen J, Jouppila P, et al. Uteroplacental and fetal circulation during extradural bupivacaine-adrenaline and bupivacaine for caesarean section in hypertensive pregnancies with chronic fetal asphyxia. Br J Anaesth. 1993 Sep;71(3):348-53.
  77. Okutomi T, Amano K, Morishima HO. Effect of standard diluted epinephrine infusion on epidural anesthesia in labor. Reg Anesth Pain Med. 2000 Sep-Oct;25(5):529-34.
  78. Yagiela JA. Adverse drug interactions in dental practice: interactions associated with vasoconstrictors. Part V of a series. J Am Dent Assoc. 1999 May;130(5):701-9.

Additional Resources

  • No Additional Resources Available